NCT07135934

Brief Summary

This randomized, double-blind, placebo-controlled crossover trial will investigate the acute effects of sodium bicarbonate supplementation on performance, stroke biomechanics, and selected physiological and perceptual responses during a simulated 200-meter Bi-Fins race in elite finswimmers.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jul 2025Dec 2026

Study Start

First participant enrolled

July 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 1, 2025

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2026

Expected
Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 1, 2025

Last Update Submit

August 20, 2025

Conditions

Keywords

Sodium BicarbonateStroke RateFinswimmingStroke LengthAthletesBiomechanicsGastrointestinal DiscomfortRate of Perceived Exertion

Outcome Measures

Primary Outcomes (3)

  • Stroke rate (SR; cycles/min)

    Calculated from video analysis to determine the number of stroke cycles per minute.

    Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.

  • Total race time (seconds)

    Total time to complete the 200-meter Bi-Fins time trial, measured using an electronic timing system. Lower values indicate better performance.

    Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.

  • Stroke length (SL; meters/cycle)

    Calculated from video analysis to determine the average distance traveled per stroke cycle.

    Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.

Secondary Outcomes (10)

  • Underwater distance (meters)

    Measured from video analysis of the 200-m Bi-Fins trial; final values reported at race completion on Day 1, Day 3, and Day 5.

  • Blood lactate concentration (mmol/L)

    Baseline (10 minutes before warm-up) and 3 minutes post-exercise on each testing day

  • Actual base excess (ABE; mmol/L)

    Baseline (10 minutes before warm-up), 10 minutes after warm-up, 5 minutes before race start, and 3 minutes post-exercise on each testing day

  • Blood bicarbonate concentration (HCO₃-; mmol/L)

    Baseline (10 minutes before warm-up), 10 minutes after warm-up, 5 minutes before race start, and 3 minutes post-exercise on each testing day

  • Rate of Perceived Exertion (RPE; score on Borg Category Ratio 1-10 scale)

    Immediately post-exercise on each testing day

  • +5 more secondary outcomes

Study Arms (2)

Placebo Comparator

PLACEBO COMPARATOR

Placebo: Food-grade starch Participants will ingest 300 mg·kg-¹ body mass of food-grade starch encapsulated in gelatin capsules 60-90 minutes prior to the simulated 200 m Bi-Fins race. Dietary Supplement: Placebo Gelatin capsules filled with food-grade starch, indistinguishable in appearance from sodium bicarbonate capsules. Water is consumed ad libitum during ingestion. Other Names: Placebo Capsules

Dietary Supplement: Placebo

Sodium Bicarbonate (NaHCO₃)

EXPERIMENTAL

Sodium Bicarbonate: NaHCO₃ Participants will ingest 300 mg·kg-¹ body mass of sodium bicarbonate encapsulated in gelatin capsules 60-90 minutes prior to the simulated 200 m Bi-Fins race. Dietary Supplement: Sodium Bicarbonate Gelatin capsules containing sodium bicarbonate (NaHCO₃), matched in appearance, weight, and texture to placebo. Water is consumed ad libitum during ingestion. Other Names: NaHCO₃ Capsules

Dietary Supplement: Sodium Bicarbonate (NaHCO3)

Interventions

Sodium Bicarbonate (NaHCO3)DIETARY_SUPPLEMENT

Gelatin capsules each containing 1g sodium bicarbonate (NaHCO₃)

Sodium Bicarbonate (NaHCO₃)
PlaceboDIETARY_SUPPLEMENT

Gelatin capsules each containing 1g food-grade starch

Placebo Comparator

Eligibility Criteria

Age15 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Member of a wider national selection in finswimming (junior or senior level)
  • Regular participation in competitive finswimming training (≥4 sessions per week)
  • Age between 15 and 30 years
  • Absence of chronic illness or injury
  • No use of medications or dietary supplements during the study period
  • Signed informed consent (for minors, also signed by a legal guardian)

You may not qualify if:

  • History of gastrointestinal disorders affecting supplement tolerance
  • Presence of cardiovascular, metabolic, or musculoskeletal disorders
  • Current illness or acute infection
  • Regular use of substances that may interfere with acid-base balance
  • Refusal to comply with pre-test restrictions (e.g., 48 hours without training)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Palacký University, Faculty of Physical Culture

Olomouc, Olomoucký kraj, 77900, Czechia

RECRUITING

MeSH Terms

Conditions

Acid-Base Imbalance

Interventions

Sodium Bicarbonate

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

BicarbonatesCarbonatesCarbonic AcidCarbon Compounds, InorganicInorganic ChemicalsSodium Compounds

Study Officials

  • Tomáš Michalica, Mgr.

    Palacký University, Faculty of Physical Culture

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tomáš Michalica, Mgr.

CONTACT

Zbyněk Svozil, Assoc. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Doctoral Researcher and Assistant Lecturer, Faculty of Physical Culture, Palacký University Olomouc

Study Record Dates

First Submitted

August 1, 2025

First Posted

August 22, 2025

Study Start

July 1, 2025

Primary Completion

August 17, 2025

Study Completion (Estimated)

December 20, 2026

Last Updated

August 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication.

Time Frame
Beginning 1 year after the publication of results with no end date.

Locations